DVA Stock Analysis: Buy, Sell, or Hold?
DVA - DaVita Inc.
$240.09
1.23 (0.51%)
▲
5d:
+1.98%
30d:
+5.29%
90d:
+54.76%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 04, 2026
TODAY
Smart Money Accumulation
None View Scanner →
Strength: 5.7/10
Get Alerted When DVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DVA trades at premium valuation expecting 10.6% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: DVA trades at premium valuation expecting 10.6% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$285.88
Based on 10.1% avg growth
INTRINSIC VALUE TODAY
$177.51
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DVA is currently trading at $240.09, which is considered extended relative to its 30-day fair value range of $223.88 to $239.16. From a valuation perspective, the stock is trading at a premium (Forward PE: 13.9) compared to its historical average (10.3). At these levels, the market is pricing in 10.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, DVA is in a strong uptrend. The price is approaching resistance at $244.49. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $208.57. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DVA is in a strong uptrend. The price is approaching resistance at $244.49. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $208.57. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$223.88 -
$239.16
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.9%
Protect Your Profits
Holding DVA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 13.1% above Wall St target ($208.57)
- NEUTRAL: Trading at premium valuation - market expects 10.6% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$223.88 -
$239.16
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$14.85
(6.2%)
Support & Resistance Levels
Support Level
$230.00
Resistance Level
$244.49
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.94
Wall Street Target
$208.57
(-13.1%)
Revenue Growth (YoY)
6.0%
Earnings Growth (YoY)
43.5%
Profit Margin
5.7%
Valuation Premium vs History
+10.6% premium
PE vs Historical
13.9 vs 10.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+10.6%
(market-implied from PE analysis)
1-Year Target
$265.54
(+11%)
2-Year Target
$293.69
(+22%)
3-Year Target
$324.82
(+35%)
3-Yr Target (if PE normalizes)
(PE: 14→10)
PE COMPRESSION
$239.98
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 16.2%)
$559.51
(+133%)
Base:
(SPY PE: 13.9, Growth: 16.2%)
$376.27
(+57%)
Bear:
(PE: 10.3, Growth: 16.2%)
$278.00
(+16%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (23x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 23.21 | Current EPS (TTM): $10.29
Bull Case
$439.74
(+83%)
Analyst growth 67.4%, PE expands to 25.5
Base Case
$399.76
(+67%)
Market implied 67.4%, PE stable at 23.2
Bear Case
$162.42
(-32%)
Severe decline -20.0%, PE contracts to 19.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 11:19 PM ET
Data refreshes hourly during market hours. Next update: 12:19 AM
Data refreshes hourly during market hours. Next update: 12:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Featured in Portfolios
DVA is a key holding in these high-performance investment strategies.
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$277 | 52 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$453 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 46 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$33 | 61 BUY |
Advanced DVA Option Strategies
Professional options setups generated by AI based on today's DVA price and gamma walls.
